Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis.
Authors: Knych Heather K, Weiner Daniel, Harrison Linda, McKemie Daniel S
Journal: BMC veterinary research
Summary
# Editorial Summary: Isoflupredone Acetate in Inflamed Joints Intra-articular corticosteroid injections remain a cornerstone of equine joint therapy, yet their behaviour in acutely inflamed joints differs substantially from non-inflamed tissue—a distinction that had not been previously characterised for isoflupredone acetate. Knych and colleagues administered isoflupredone to horses with lipopolysaccharide-induced synovitis and tracked both drug concentrations (pharmacokinetics) and clinical effects including lameness, joint circumference, and range of motion over time. Inflammation significantly altered drug kinetics compared to healthy joints, with systemic absorption patterns changing whilst synovial fluid concentrations remained therapeutically relevant for an extended period. Joint effusion decreased and lameness improved measurably following injection, supporting the anti-inflammatory efficacy of the steroid in this acute inflammatory model. These findings have direct relevance for practitioners selecting doses and timing of intra-articular isoflupredone in performance horses presenting with active synovitis, suggesting that inflamed joint tissue may retain therapeutic drug concentrations longer than previously assumed from studies in non-inflamed joints.
Read the full abstract on PubMed
Practical Takeaways
- •Intra-articular isoflupredone delivers therapeutic drug concentrations directly to inflamed joints with minimal systemic absorption, reducing doping concerns in performance horses
- •The presence of joint inflammation changes how intra-articular corticosteroids behave pharmacologically, which may influence dosing decisions in acute versus chronic joint conditions
- •This data supports intra-articular corticosteroid use for managing joint inflammation in performance horses when systemic effects need to be minimized
Key Findings
- •Intra-articular isoflupredone acetate produced low and brief blood concentrations while maintaining higher synovial fluid concentrations in non-inflamed joints
- •Acute synovitis inflammation altered the pharmacokinetics of isoflupredone acetate compared to non-inflamed joint conditions
- •Pharmacodynamic effects of isoflupredone were measured including changes in joint circumference, joint flexion, and lameness in the experimental synovitis model